Study record

The DNA-dependent protein kinase catalytic subunit exacerbates endotoxemia-induced myocardial microvascular injury by disrupting the MOTS-c/JNK pathway and inducing profilin-mediated lamellipodia degradation

Zou R, Shi W, Chang X et al. · Theranostics · 2024

AnimalSeveralEvidence tier CAlso: Cell study (in vitro)

What this study reported

Reported that lipopolysaccharide increased DNA-PKcs activity in mouse cardiac microvascular endothelial cells and repressed MOTS-c transcription, while endothelial DNA-PKcs deletion or inhibition reduced microvascular dysfunction. In the same models, MOTS-c supplementation was associated with better endothelial barrier function, and loss of MOTS-c allowed JNK to phosphorylate profilin and destabilise lamellipodia.

Limitations

Single acute endotoxemia model with group sizes, sex and blinding not reported; the mechanism is inferred from proteomics plus pharmacological inhibitors and a mutant construct in one cell type.

Study record

Annotated fields for this study
Study modelAnimal study (in vivo)
Substance studiedSeveralMore than one of these is central to the paper (common for reviews).
Speciesmouse
System studiedEndothelial cell-specific DNA-PKcs knockout mice given lipopolysaccharide, and cardiac microvascular endothelial cells
PopulationNot reported
DesignControlled animal experiment with cell and proteomic assays
Sample size as reportedNot reported
Control groupwild-type lipopolysaccharide-treated mice and untreated cells
Route (data field only)Not reported
Endpoints measuredmyocardial microvascular function; endothelial barrier function; MOTS-c transcription; JNK activity and profilin phosphorylation; mitochondrial fission
Pathways measuredMAPK signalling · Inflammation
Research areasCardiovascular · Inflammation & immunity
Evidence tierC — Animal in vivo
Publication typesJournal Article, Research Support, Non-U.S. Gov't

Appraisal

Each dimension is recorded separately and never combined into a single score. A study can be well controlled and still tell you little about people.

Relevance to MOTS-c
Direct
Model applicability
Mammalian
Sample size
Not reported
Controls
Appropriate
Outcome validity
Surrogate
Support for its own conclusion
Moderate

Provenance

  • Bibliographic fields retrieved from PubMed E-utilities efetch (title, journal, date, authors, DOI) on 2026-11-11.
  • Annotated from the published abstract.
  • Editorial review: approved (2026-11-11).
  • Classification follows the site methodology; the record describes the study, not what MOTS-c does in people.